FDAFDA · Food and drugs·Recall number D-0926-2017
Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg, 100-count bottles, Distributed by: GlaxoSmithKline Consumer Healthcare, L.P., Moon Twp, PA 15108, UPC 3 0088-1175-47 8.
Published July 5, 2017 · Recall initiated: June 12, 2017
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug: high out-of-specification result for magnesium.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Sanofi-Aventis U.S. LLC
- Distributor
- Nationwide in the USA, Puerto Rico, and the United Kingdom.
- Lot
- Lot #: 5J69A, Exp 02/19; 6GF2A, 6GF3A, Exp 08/19
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.